The 2 Minute Medicine® Podcast

We begin this episode by discussing our article of the week from Pediatrics, entitled “HIV Preexposure Prophylaxis Provision among Adolescents: 2018 to 2021”.  We then dive deeper into a discussion about seasonal affective disorder, its treatment, and its impact on the population. Then we take a closer look at the Movember movement and how it relates to men’s health. After that, we discuss the recent surge in syphilis cases and what can be done about it. Last, but not least, we have a conversation about substance use disorders in the wake of Matthew Perry’s passing. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from Pediatrics, entitled “COVID-19 Vaccine Hesitancy Among Parents: A Qualitative Study”. In the second half of our episode, we start off by discussing the issue of performance-enhancing drugs in sports following the news of a  banned substance scandal in the men's marathon. Next, we will dive into the NHL's Pride Tape ban and their decision to reverse the ban following public push-back. Finally, we end with conversations about the bedbug outbreak in Paris, and new studies highlighting the value of wearable technology in diagnosing and monitoring Parkinson's disease. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled ““Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea.” In the second half of our episode, we begin by taking a closer look at the public heath crisis in Gaza. Next, we discuss a recently published study in JAMA, and examine the possible link between ADHD and Dementia. Last but not least, a short discussion about the significance of October being National Pregnancy and Infant Loss Awareness Month. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled “Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH”. In the second half of our episode, we begin by exploring the recently announced price drop for a popular tuberculosis test. Then we discuss Sufjan Stevens' ongoing battle with the rare autoimmune condition, Guillain-Barre Syndrome. Finally, we end with a conversation about newly developed tests to identify medical abortions and the ongoing American Red Cross blood supply shortage. 

We begin this episode by discussing our article of the week from JAMA Network Open, entitled “Women’s Adherence to Healthy Dietary Patterns and Outcomes of Infertility Treatment”. In the second half of our episode, we begin with a discussion about Shohei Ohtani, the superstar baseball player fighting against a torn ligament. Next, we look at blue light glasses, an increasingly popular way to combat eye strain in the digital world. After that, we discuss sciatica, and how this disease affects the lives of many, including some famous names. Finally, we discuss the long-term and short-term impacts of concussion and CTE.

We begin this episode by discussing our article of the week from the Lancet “Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA”. In the second half of our episode, we begin with a discussion of Wegovy and the latest data on its human use. Next, we discuss congenital heart disease in sports. Following that, we examine the latest developments with the COVID-19 virus, and last but not least, we examine the recent news about long-lasting chemicals found in paper straws, and their impact on human health.

We begin this episode by discussing our article of the week from from the New England Journal of Medicine, entitled “Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.” In the second half, we have a conversation about Alzheimer's disease and how a drug called Donanemab has shown a 29% slower rate of decline and cognitive function. Next, we look at complications of bariatric surgery, the medical effects of heat exhaustion and what we can do to prevent it, and conclude with a conversation about energy drinks and it's lesser known side effects.

We begin this episode by discussing our article of the week from JAMA and is entitled, “Trends in Rates of Opioid Agonist Treatment and Opioid-Related Deaths for Youths in Ontario, Canada, 2013-2021. In the second half of our episode, we begin by discussing the FIFA Women's World Cup and some of the strides taken to protect and support female athletes. Then we discuss National Immunization Awareness Month and some health tips for heading back-to-school. Finally, we conclude with a discussion on Overdose Awareness Day and the importance of naloxone in preventing deaths due to overdose.

We begin this episode by discussing our article of the week from BMC medicine, “Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial”. In the second half of our episode, we begin with a discussion about a blood test that was recently approved by the federal drug administration that can detect those at a greater risk for pre-eclampsia. Then we discuss the American Medical Association's new policy regarding the use of BMI in medical practice. Finally, we end with a conversation about Madonna's recent sepsis scare, as well as some of the injuries seen in the latest edition of the Tour de France.

We begin this episode by discussing our article of the week from the New England Journal of Medicine entitled “Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.”In the second half of our episode, we begin with a discussion about how the Supreme Court of the United States may impact college admissions for the foreseeable future. Then we explore the latest information regarding the link between a beloved artificial sweetener, and cancer. Last, but not least, we have a conversation about blood clots along with the stars who have experienced them, and psychedelics, a class of drugs recently approved for mental health treatment in Australia!